VIDEO: Vevye improves Schirmer’s scores by 98%
Click Here to Manage Email Alerts
ATLANTA — A long-term study of Vevye for treating dry eye showed an improvement in Schirmer’s scores by 98% at week 46, according to Walter O. Whitley, OD, MBA, FAAO.
Harrow’s Vevye contains cyclosporine 0.1%, with perfluorobutylpentane as the carrier, allowing it “to get into the tissue and render its effect,” Whitley, director of optometric services at Virginia Eye Consultants in Norfolk, said in this Healio video.
The 98% increase in Schirmer’s score at 56 weeks is important because, “we know that with Schirmer’s, we’re improving the tear,” he said. “The natural tear is so important [because it has] antimicrobial proteins, lactoferrin, lysozyme, the electrolytes, the mucin and all the growth factors for clear comfortable vision.”
Editor's note: On March 2, 2024, one of the data points in this article was updated.
References:
- Akpek EK, et al. JAMA Ophthalmol. 2023;doi:10.1001/jamaophthalmol.2023.0709.
- Sheppard JD, et al. Cornea. 2021;doi:10.1097/ICO.0000000000002633.
Collapse
Healio Interviews
Read more about
Click Here to Manage Email Alerts